A Study to Compare ORMD-0801 Once Daily to ORMD-0801 Three Times Daily in Subjects With Type 1 Diabetes

NCT04150107 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 1 Diabetes

Interventions

DRUG: ORMD-0801 Treatment A
DRUG: ORMD-0801 Treatment B
OTHER: Placebo

Sponsor

Oramed, Ltd.

Collaborators

[object Object]